Patient compliance in the treatment of arterial hypertension

Jm, Mallion; Schmitt, Dominik

doi:10.1097/00004872-200112000-00024

Cited by 25 publications

(18 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Self-reporting was used as the only measure of compliance, and this may lead to overestimation. 36 Lim et al 34 reported only 71% sensitivity and 50% specificity of self-report as a measure of compliance when compared with pill count. A combination of self-report and objective measures may yield a higher accuracy concerning compliance behaviours.…”

Section: Discussionmentioning

confidence: 99%

Identification of psychosocial factors of noncompliance in hypertensive patients

et al. 2005

View full text Add to dashboard Cite

This cross-sectional study was aimed to identify the predictors of medication noncompliance in hypertensive patients. The study was conducted at the Family Medicine Clinic, Hospital Universiti Sains Malaysia, Kelantan, Malaysia, which is a university-based teaching hospital. All hypertensive patients aged 40 or overregistered from January to June 2004, who had been on treatment for at least 3 months, were screened. Previously validated self-administered questionnaires were used to assess the compliance and psychosocial factors. A total of 240 hypertensive patients were recruited in the study. Of these, 55.8% were noncompliant to medication. Logistic regression showed that age (adjusted odds ratio (OR): 0.96; 95% confidence interval (CI): 0.92-0.997; P: 0.035), patient satisfaction (adjusted OR: 0.97; 95% CI: 0.93-0.998; P: 0.036) and medication barrier (adjusted OR: 0.95; 95% CI: 0.91-0.987; P: 0.009) were significant predictors of medication noncompliance. Therefore, younger age, poor patient satisfaction and medication barrier were identified as independent psychosocial predictors of medication noncompliant in hypertensive patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Identification of psychosocial factors of noncompliance in hypertensive patients

et al. 2005

View full text Add to dashboard Cite

show abstract

“…Gallup [6] recognized in his study that 11% of patients treated with an antihypertensive stopped their treatment because of undesirable side effects, 25% because they thought that their doctor had asked them to stop, 46% because they thought they had been cured and 6% for financial reasons [6] . Mallion and Schmitt [5] found in his study that the therapeutic class of the antihypertensive drugs affect the compliance too [5] . Second generation angiotensin antagonists have the best level of compliance followed by converting enzyme inhibitors, calcium blockers, beta blockers and diuretics [5] .…”

Section: Introductionmentioning

confidence: 99%

“…Mallion and Schmitt [5] found in his study that the therapeutic class of the antihypertensive drugs affect the compliance too [5] . Second generation angiotensin antagonists have the best level of compliance followed by converting enzyme inhibitors, calcium blockers, beta blockers and diuretics [5] . Bloom [7] recognized data from a large pharmacy database in the United States that when assessing compliance, rates at 1 year, patients treated with angiotensin receptor blockers had greater compliance rates than those treated with other classes of antihypertensive agents.…”

Section: Introductionmentioning

confidence: 99%

“…The treatment: The medication's undesirable side effects are a major deterrent to good patient compliance. The more the side effects, the less patient compliance to these medications [5] . Gallup [6] recognized in his study that 11% of patients treated with an antihypertensive stopped their treatment because of undesirable side effects, 25% because they thought that their doctor had asked them to stop, 46% because they thought they had been cured and 6% for financial reasons [6] .…”

Section: Introductionmentioning

confidence: 99%

“…The therapeutic environment: The prescription that the physician has written for a specific patient may affect his compliance. The greater the number of antihypertensive medications or number of tablets taken daily the less the compliance is [5] . Christopher M. Dezii [8] in his retrospective study recognized that patients are more adherent to once daily regimens than multiple daily regimens [8] .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Variability in Antihypertensive Drug Therapy and Compliance: Results from a Random Survey in the United Arab Emirates

Sulaiman¹,

Alomar²,

Strauch³

2009

American J. of Pharmacology and Toxicology

View full text Add to dashboard Cite

Problem statement: Hypertension is one of the most common diseases known as the 'silent killer' because it shows no clinical signs and symptoms. The high prevalence of hypertension in the United Arab Emirates stresses the importance to initiate a nation-wide effort to prevent and control high blood pressure in the population, especially since the prevalence rates are indicative of one of the highest in the world. Approach: This study was designed to investigate the prevalence of hypertension and antihypertensive medications in the United Arab Emirates-Abu Dhabi. A cross-sectional descriptive survey of one hundred sixty hypertensive patient ranging in age from 30 to above 60 years was carried out. A detailed questionnaire was printed out and distributed randomly among hypertensive patients in selected places in Abu Dhabi (pharmacies and hospitals). Results: UAE is a multicultural country with various nationalities living together. 26% of the patients included in this study were UAE nationals followed by Indians (15%). The prevalence of hypertension in males was higher than that in females. There was higher prevalence of hypertension in married patients (80.6%) as compared with the unmarried group (19.4%). A correlation exists between the high workload and the prevalence of hypertension. 36.2% of the individuals with mild obesity were hypertensive, while 26.2% of them were moderately obese. Obesity is certainly an important factor accounting for hypertension. It is observed that the worst association was obesity and familial history of hypertension, which had a prevalence of 27%, compared with other factors. Conclusion: Physicians, pharmacists and nurses should educate patients to understand their disease process which will help to improve compliance. It was suggested that programs for controlling systemic hypertension should be put in priority and better instructions for the population about the reasons that could make compliance with the antihypertensive treatment difficult, jeopardizing the appropriate control of blood pressure and increasing cardiovascular morbidity and mortality.

show abstract